Concepedia

Cyclacel Pharmaceuticals (United Kingdom)

CP

194

Publications

39K

Citations

38

Authors

Dundee

United Kingdom

Cyclacel Pharmaceuticals (United Kingdom) is a company institution in Dundee, United Kingdom known for medicine, drug discovery, and pharmacology.

HomepageWikipediaROR

Top concepts

Publications

194

<i>In vitro</i> and <i>in vivo</i> antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R‐roscovitine)

Steven J. McClue, David Blake, Rosemary G. Clarke et al. · International Journal of Cancer · 2002 · 363 citations · Full text

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2 <sup>+</sup> breast cancer patients

Maurizio Scaltriti, Pieter J.A. Eichhorn, Javier Cortés et al. · Proceedings of the National Academy of Sciences · 2011 · 320 citations

An in vitro model of angiogenesis: Basic features

Eileen Bishop · Angiogenesis · 1999 · 308 citations

Seliciclib (CYC202, R-Roscovitine) Induces Cell Death in Multiple Myeloma Cells by Inhibition of RNA Polymerase II–Dependent Transcription and Down-regulation of Mcl-1

David E. MacCallum, Jean Melville, Sheelagh Frame et al. · Cancer Research · 2005 · 284 citations · Full text

, , +16

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days

Charlotte Benson, Jeff White, Johann S. de Bono et al. · British Journal of Cancer · 2006 · 257 citations · Full text

Rows per page

1–5 of 194

Authors

38

PublicationsCitationsH-Index
SR
Simon R. Green

Cyclacel Pharmaceuticals (United Kingdom)

104

3.8K

29

DZ
Daniella Zheleva

Cyclacel Pharmaceuticals (United Kingdom)

91

3K

25

AG
Athos Gianella-Borradori

Cyclacel Pharmaceuticals (United Kingdom)

65

3.7K

25

AB
Anna Barnett

Cyclacel Pharmaceuticals (United Kingdom)

42

1.1K

21

SJ
Steven J. McClue

Cyclacel Pharmaceuticals (United Kingdom)

35

1.6K

20

Rows per page

1–5 of 38